← Open Payments lookup

GEOFFREY PLUMLEE: Open Payments

NPI 1538133640 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$51,014 in 306 payments from 27 companies in 2025. Trend: 2023 $37,051 · 2024 $55,425 · 2025 $51,014

Consulting: $46,000Food & beverage: $4,939Education: $75
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.30$46,113
AstraZeneca Pharmaceuticals LP25$701
ABBVIE INC.49$533
Corium, LLC21$389
Boehringer Ingelheim Pharmaceuticals, Inc.16$324
Novo Nordisk Inc20$319
Axsome Therapeutics, Inc.11$309
PFIZER INC.18$308
GlaxoSmithKline, LLC.25$303
Lilly USA, LLC11$274

Products named: REXULTI, Azstarys, FARXIGA, JARDIANCE, Auvelity, TRELEGY ELLIPTA, LINZESS, CAPLYTA.

Industry payments across OK — which companies pay providers there.